500 mg gallic acid equivalent (GAE), twice daily, 12 months

Prediabetes

Oil Palm Phenolics

Placebo

Seberang Jaya Hospital

Modulating Effects of Oil Palm Phenolics in Subjects With Pre-diabetes

Serum Glycosylated Haemogoblin (<5.7% indicates healthy, 5.7% - 6.4% indicates prediabetes, >6.5% indicates diabetes)
Plasma glucose level of oral glucose tolerance test (<7.8 mmol/L indicates healthy, 7.8 mmol/L - 11 mmol/L indicates prediabetes, >11 mmol/L indicates diabetes)
Fasting plasma glucose level (<5.6 mmol/L indicates healthy, 5.6 mmol/L - 6.9 mmol/L indicates prediabetes, >6.9 mmol/L indicates diabetes)

Model-derived Oral Glucose Insulin Sensitivity (OGIS) Index will be calculated using weight (kg), height (cm), glucose (mmol/L) and insulin (pmol/L).

Total cholesterol, Low-density lipoprotein, High-density lipoprotein, Triglycerides

Very good, good, no change, unsatisfactory and very unsatisfactory

Homeostatic Model Assessment (HOMA2-B) to determine beta cell function

Yuen Kah Hay

Professor, Dr.

Universiti Sains Malaysia

Malaysia Palm Oil Board

Clinical Research Centre, Malaysia

500 mg gallic acid equivalent (GAE), twice daily, 3 months

Uncontrolled Insulin-treated Type 2 Diabetes Mellitus

Modulating Effects of Oil Palm Phenolics in Uncontrolled Insulin-treated Type 2 Diabetes Mellitus

Very good, Good, No change, Unsatisfactory, Very unsatisfactory

protocatechuic acid/bólga

Modulating Effects of Oil Palm Phenolics in Subjects With Pre-diabetes

Modulating Effects of Oil Palm Phenolics in Uncontrolled Insulin-treated Type 2 Diabetes Mellitus

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum